Patent ID: 9211330
Filing Date: 2015-12-15
Classification: A61K,A61P,C07K

Abstract:
1. A method for treating a disease or disorder that is associated with A-beta deposition, wherein said method comprises administering to a subject in need thereof a pharmaceutically active amount of at least one polypeptide, wherein said polypeptide comprises a first immunoglobulin single variable domain and a second immunoglobulin single variable domain, wherein the CDR sequences of said first immunoglobulin variable domain (CDR(1) sequences) and the CDR sequences of said second immunoglobulin variable domain (CDR(2) sequences) are defined as follows: CDR(1)1: SEQ ID NO:17 CDR(1)2: SEQ ID NO:18 CDR(1)3: SEQ ID NO:19 CDR(2)1: SEQ ID NO:14 CDR(2)2: SEQ ID NO:15 CDR(2)3: SEQ ID NO:16, or CDR(1)1: SEQ ID NO:14 CDR(1)2: SEQ ID NO:15 CDR(1)3: SEQ ID NO:16 CDR(2)1: SEQ ID NO:17 CDR(2)2: SEQ ID NO:18 CDR(2)3: SEQ ID NO:19.